Medicare Enrolled
Dr. Videsha Kulkarni, MD
Internal Medicine · Glenview, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kulkarni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kulkarni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kulkarni
Dr. Videsha Kulkarni is an internal medicine specialist in Glenview, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kulkarni performed 1,288 Medicare services across 1,038 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kulkarni received a total of $11,973 from 53 pharmaceutical and/or device companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kulkarni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in IL
$11,973 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,288
Medicare services
Top 26% in IL for internal medicine
1,038
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
272 | $92 | $196 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $67 | $131 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
141 | $61 | $177 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
135 | $8 | $20 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
120 | $12 | $81 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
113 | $137 | $270 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
59 | $2 | $20 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
34 | $18 | $54 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $16 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
29 | $32 | $42 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
28 | $40 | $231 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
27 | $70 | $85 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
27 | $283 | $377 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
27 | $32 | $42 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
25 | $43 | $75 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
25 | $128 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $127 | $272 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
16 | $176 | $270 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
15 | $10 | $81 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,973
Total received (2018-2024)
Avg $1,710/year across 7 years
Top 6% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
697
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,935 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,894
2023
$1,628
2022
$1,488
2021
$1,739
2020
$1,580
2019
$1,792
2018
$1,852
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$296
ABBVIE INC.
$288
GlaxoSmithKline, LLC.
$236
Lilly USA, LLC
$223
Novo Nordisk Inc
$142
AstraZeneca Pharmaceuticals LP
$140
Amneal Pharmaceuticals LLC
$136
Amgen Inc.
$95
Esperion Therapeutics, Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
Medtronic, Inc.
$53
Merck Sharp & Dohme LLC
$51
E.R. Squibb & Sons, L.L.C.
$28
Exact Sciences Corporation
$27
Noven Therapeutics, LLC
$18
Inspire Medical Systems, Inc.
$18
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,773
ABBVIE INC.
$1,142
AstraZeneca Pharmaceuticals LP
$1,120
Lilly USA, LLC
$901
PFIZER INC.
$766
Boehringer Ingelheim Pharmaceuticals, Inc.
$552
Janssen Pharmaceuticals, Inc
$540
Amgen Inc.
$507
AbbVie Inc.
$487
GlaxoSmithKline, LLC.
$429
Amneal Pharmaceuticals LLC
$407
Currax Pharmaceuticals LLC
$308
Takeda Pharmaceuticals U.S.A., Inc.
$287
Amarin Pharma Inc.
$207
Kowa Pharmaceuticals America, Inc.
$181
Allergan, Inc.
$180
Supernus Pharmaceuticals, Inc.
$171
Merck Sharp & Dohme Corporation
$168
Allergan Inc.
$150
AbbVie, Inc.
$132
VIVUS, Inc.
$130
Esperion Therapeutics, Inc.
$110
Astellas Pharma US Inc
$99
IDORSIA PHARMACEUTICALS US INC
$96
Teva Pharmaceuticals USA, Inc.
$82
Novartis Pharmaceuticals Corporation
$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$78
Exact Sciences Corporation
$76
Biohaven Pharmaceutical Holding Company Ltd.
$71
SANOFI PASTEUR INC.
$62
Avanir Pharmaceuticals, Inc.
$54
Medtronic, Inc.
$53
Merck Sharp & Dohme LLC
$51
Gemini Laboratories, LLC
$45
IBSA Pharma Inc.
$44
E.R. Squibb & Sons, L.L.C.
$42
Horizon Therapeutics plc
$42
Eisai Inc.
$38
Shire North American Group Inc
$37
Biohaven Pharmaceuticals, Inc.
$35
Circassia Pharmaceuticals Inc
$34
MAYNE PHARMA COMMERCIAL LLC
$30
ARBOR PHARMACEUTICALS, INC.
$29
Noven Therapeutics, LLC
$18
Inspire Medical Systems, Inc.
$18
Sanofi Pasteur Inc.
$16
SK Life Science, Inc.
$15
Horizon Pharma plc
$15
Adlon Therapeutics L.P.
$14
Hologic, LLC
$13
EISAI INC.
$13
Nalpropion Pharmaceuticals LLC
$12
Mission Pharmacal Company
$11
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
ADACEL · ADHANSIA XR · ADVAIR · AIRSUPRA · AJOVY · AREXVY · Aimovig · AirDuo Digihaler · Aptima Tricomonas · BASAGLAR · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Belviq · CHANTIX · CONTRAVE · Cologuard Collection Kit · Corlanor · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · Ferralet · GARDASIL · GATTEX · HUMALOG · INSPIRE · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · LINZESS · LYRICA · Licart · Livalo · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · NEXLETOL · NEXTSTELLIS · NUEDEXTA · NURTEC ODT · ONZETRA XSAIL · Otezla · Otovel · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 20 · Prolia · QSYMIA · QULIPTA · QUVIVIQ · QVAR RediHaler · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · Tirosint · Tresiba · Trintellix · UBRELVY · UNITHROID · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xelstrym · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in IL.
Geographic Context
Internal medicine physicians within 10 mi
5,686
Per 100K population
109.6
County median income
$81,797
Nearest hospital
CHICAGO BEHAVIORAL HOSPITAL
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kulkarni is a clinical cardiology specialist, with above-average Medicare volume (top 26% in IL), with low-engagement industry engagement in the top 6% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kulkarni experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kulkarni performed 272 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kulkarni receive payments from pharmaceutical companies?
Yes. Dr. Kulkarni received a total of $11,973 from 53 companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kulkarni's costs compare to other internal medicine physicians in Glenview?
Dr. Kulkarni's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kulkarni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Glenview
Browse internal medicine physicians in Glenview ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in IL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in IL
Which IL internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology